Evidence map›Paper›PMID 36097293›Full record

ArticleNature structural & molecular biology2022

Visualizing maturation factor extraction from the nascent ribosome by the AAA-ATPase Drg1.

Michael Prattes, Irina Grishkovskaya, Victor-Valentin Hodirnau, Christina Hetzmannseder, Gertrude Zisser, Carolin Sailer, Vasileios Kargas, Mathias Loibl, Magdalena Gerhalter, Lisa Kofler and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Nature structural & molecular biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 4 countries.

Michael Prattes *Institute of Molecular Biosciences, University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0002-2526-9896
Irina Grishkovskaya *Research Institute of Molecular Pathology (IMP), Vienna BioCenter, Vienna, Austria.ORCID http://orcid.org/0000-0003-0164-9373
Victor-Valentin HodirnauInstitute of Science and Technology Austria, Klosterneuburg, Austria.ORCID http://orcid.org/0000-0003-3904-947X
Christina HetzmannsederInstitute of Molecular Biosciences, University of Graz, Graz, Austria.
Gertrude ZisserInstitute of Molecular Biosciences, University of Graz, Graz, Austria.
Carolin SailerDepartment of Biology, University of Konstanz, Konstanz, Germany.
Vasileios KargasCambridge Institute for Medical Research, Cambridge Biomedical Campus, Cambridge, UK.
Mathias LoiblInstitute of Molecular Biosciences, University of Graz, Graz, Austria.
Magdalena GerhalterInstitute of Molecular Biosciences, University of Graz, Graz, Austria.
Lisa KoflerInstitute of Molecular Biosciences, University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0002-8894-8802
Alan J WarrenCambridge Institute for Medical Research, Cambridge Biomedical Campus, Cambridge, UK.ORCID http://orcid.org/0000-0001-9277-4553
Florian StengelDepartment of Biology, University of Konstanz, Konstanz, Germany.ORCID http://orcid.org/0000-0003-1447-4509
David HaselbachResearch Institute of Molecular Pathology (IMP), Vienna BioCenter, Vienna, Austria. david.haselbach@imp.ac.at.ORCID http://orcid.org/0000-0002-5276-5633
Helmut BerglerInstitute of Molecular Biosciences, University of Graz, Graz, Austria. helmut.bergler@uni-graz.at.ORCID http://orcid.org/0000-0002-7724-309X
University of Graz · ATResearch Institute of Molecular Pathology · ATUniversity of Konstanz · DEWellcome/MRC Cambridge Stem Cell Institute · GBInstitute of Science and Technology Austria · AT

Funding

Austrian Science Fund FWF P 32536Austrian Science Fund FWF P 32977Medical Research Council MR/T012412/1
6 · The paper itself

Abstract

The AAA-ATPase Drg1 is a key factor in eukaryotic ribosome biogenesis that initiates cytoplasmic maturation of the large ribosomal subunit. Drg1 releases the shuttling maturation factor Rlp24 from pre-60S particles shortly after nuclear export, a strict requirement for downstream maturation. The molecular mechanism of release remained elusive. Here, we report a series of cryo-EM structures that captured the extraction of Rlp24 from pre-60S particles by Saccharomyces cerevisiae Drg1. These structures reveal that Arx1 and the eukaryote-specific rRNA expansion segment ES27 form a joint docking platform that positions Drg1 for efficient extraction of Rlp24 from the pre-ribosome. The tips of the Drg1 N domains thereby guide the Rlp24 C terminus into the central pore of the Drg1 hexamer, enabling extraction by a hand-over-hand translocation mechanism. Our results uncover substrate recognition and processing by Drg1 step by step and provide a comprehensive mechanistic picture of the conserved modus operandi of AAA-ATPases.

Indexed as

Adenosine TriphosphatasesATPases Associated with Diverse Cellular ActivitiesRibosomal ProteinsRibosomesRibosome Subunits, Large, EukaryoticSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsAdenosine TriphosphatasesAFG2 protein, S cerevisiaeArx1 protein, S cerevisiaeATPases Associated with Diverse Cellular ActivitiesRibosomal ProteinsSaccharomyces cerevisiae Proteins

Identifiers

PMID36097293
PMCPMC9507969
OpenAlexW4295427504

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.